+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Gastroesophageal Reflux Disease Devices Market by Product Type, Procedure Type, Surgery Type, Device Type, Dosage Form, Route of Administration, End-User - Global Forecast 2025-2030- Product Image
Gastroesophageal Reflux Disease Devices Market by Product Type, Procedure Type, Surgery Type, Device Type, Dosage Form, Route of Administration, End-User - Global Forecast 2025-2030- Product Image
Sale

Gastroesophageal Reflux Disease Devices Market by Product Type, Procedure Type, Surgery Type, Device Type, Dosage Form, Route of Administration, End-User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 188 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 5456959
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Gastroesophageal Reflux Disease Devices Market grew from USD 5.85 billion in 2023 to USD 6.65 billion in 2024. It is expected to continue growing at a CAGR of 13.66%, reaching USD 14.35 billion by 2030.

The market for Gastroesophageal Reflux Disease (GERD) devices is witnessing significant growth due to rising incidences of GERD, attributed to lifestyle changes and increasing obesity rates. The market scope and definition encompass devices like LINX systems, endoscopic treatments, and fundoplication devices, essential for providing alternatives to pharmaceutical therapies in GERD management. The necessity of these devices is driven by patient demand for minimally invasive treatment options, effectiveness in reducing dependency on medications, and improving quality of life. Applications are broad, focusing on healthcare settings such as hospitals, ambulatory surgical centers, and specialty clinics that aim to enhance patient outcomes through technologically advanced solutions.

End-use scope is expanding as awareness increases among patients and healthcare providers. Key growth factors include technological advancements in device development, increasing healthcare expenditures, and heightened patient awareness. Opportunities exist in the development of customizable, patient-specific devices and data-integrative GERD management systems. It is recommended for companies to invest in R&D for innovative device functionality, such as smart diagnostic capabilities or integration with wearable health tech, capitalizing on advances in IoT and artificial intelligence. Meanwhile, partnerships with healthcare providers to improve device adoption rates could bolster market penetration.

Limitations include regulatory barriers, high costs associated with advanced GERD devices, and limited insurance coverage in certain regions, which challenge widespread adoption. Additionally, market growth is constrained by competition from pharmaceutical treatments and ongoing debates over the efficacy of certain devices. Innovation areas include the improvement of device biocompatibility, miniaturization, and the integration of real-time monitoring features. Research could focus on enhancing surgical techniques and postoperative care to reduce complications. The GERD device market is characterized by rapid technological advancements, regulatory scrutiny, and necessitates strategic alliances and focused R&D efforts for sustained growth and leadership.

Understanding Market Dynamics in the Gastroesophageal Reflux Disease Devices Market

The Gastroesophageal Reflux Disease Devices Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Rising aging population across the world
    • Growing obese population and their preference for surgeries
    • Surge in adoption among diagnostic centers and private clinics
  • Market Restraints
    • Availability of alternative such as proton pump inhibitors
  • Market Opportunities
    • Robust innovation and launch of new advanced products in the market
    • Ongoing trend of self-medication and awareness of the disease
  • Market Challenges
    • Decreased acceptability of devices an dearth of standard regulatory approval

Exploring Porter’s Five Forces for the Gastroesophageal Reflux Disease Devices Market

Porter’s Five Forces framework further strengthens the insights of the Gastroesophageal Reflux Disease Devices Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Gastroesophageal Reflux Disease Devices Market

External macro-environmental factors deeply influence the performance of the Gastroesophageal Reflux Disease Devices Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Gastroesophageal Reflux Disease Devices Market

The Gastroesophageal Reflux Disease Devices Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Gastroesophageal Reflux Disease Devices Market

The Gastroesophageal Reflux Disease Devices Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Gastroesophageal Reflux Disease Devices Market

The Gastroesophageal Reflux Disease Devices Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Gastroesophageal Reflux Disease Devices Market, highlighting leading vendors and their innovative profiles. These include Addex Pharmaceuticals Ltd., Aros Pharma ApS, AstraZeneca PLC, C. R. Bard, Inc., Eisai Co., Ltd., EndoGastric Solutions, Inc., Frost & Sullivan Inc., Johnson & Johnson Services, Inc., KARL STORZ SE & Co. KG, MediGus Ltd., Olympus Corporation, PENTAX Europe GmbH, Pfizer Inc., Takeda Pharmaceutical Company Limited, and The Procter & Gamble Company.

Market Segmentation & Coverage

This research report categorizes the Gastroesophageal Reflux Disease Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Product Type
    • Diagnostic Devices
    • Esophagoscopes & Gastroscopes
    • Fundoplication Devices
    • Manometry System
    • PH Monitoring System
    • Radiofrequency Ablation Devices
    • Sphincter Augmentation Devices
    • Treatment Devices
    • Ultrasonic Surgical Endostapler
  • Procedure Type
    • Diagnostic Procedures
    • Fundoplication Procedures
    • Magnetic Sphincter Augmentation
    • Radiofrequency Thermal Ablation
  • Surgery Type
    • Invasive
      • Linx Reflux Management
      • Medigus Ultrasonic Surgical Endostapler
    • Non-Invasive
      • Endocinch Endolumminal Gastroplication
      • Endoscopic Plicator System
      • EsophyX
      • Plexiglas Poly-Methyl-Methacrylate Microspheres
      • Stretta
  • Device Type
    • Bravo Reflux Testing System
    • Digitrapper reflux testing system
    • LINX Management System
    • MUSE -Medigus Ultrasonic Surgical Endostapler
    • Stretta Therapy
  • Dosage Form
    • Liquid
    • Solid
  • Route of Administration
    • Oral
    • Parenteral
  • End-User
    • Government
    • Hospitals
    • Medical Practitioners
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising aging population across the world
5.1.1.2. Growing obese population and their preference for surgeries
5.1.1.3. Surge in adoption among diagnostic centers and private clinics
5.1.2. Restraints
5.1.2.1. Availability of alternative such as proton pump inhibitors
5.1.3. Opportunities
5.1.3.1. Robust innovation and launch of new advanced products in the market
5.1.3.2. Ongoing trend of self-medication and awareness of the disease
5.1.4. Challenges
5.1.4.1. Decreased acceptability of devices an dearth of standard regulatory approval
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Gastroesophageal Reflux Disease Devices Market, by Product Type
6.1. Introduction
6.2. Diagnostic Devices
6.3. Esophagoscopes & Gastroscopes
6.4. Fundoplication Devices
6.5. Manometry System
6.6. PH Monitoring System
6.7. Radiofrequency Ablation Devices
6.8. Sphincter Augmentation Devices
6.9. Treatment Devices
6.10. Ultrasonic Surgical Endostapler
7. Gastroesophageal Reflux Disease Devices Market, by Procedure Type
7.1. Introduction
7.2. Diagnostic Procedures
7.3. Fundoplication Procedures
7.4. Magnetic Sphincter Augmentation
7.5. Radiofrequency Thermal Ablation
8. Gastroesophageal Reflux Disease Devices Market, by Surgery Type
8.1. Introduction
8.2. Invasive
8.2.1. Linx Reflux Management
8.2.2. Medigus Ultrasonic Surgical Endostapler
8.3. Non-Invasive
8.3.1. Endocinch Endolumminal Gastroplication
8.3.2. Endoscopic Plicator System
8.3.3. EsophyX
8.3.4. Plexiglas Poly-Methyl-Methacrylate Microspheres
8.3.5. Stretta
9. Gastroesophageal Reflux Disease Devices Market, by Device Type
9.1. Introduction
9.2. Bravo Reflux Testing System
9.3. Digitrapper reflux testing system
9.4. LINX Management System
9.5. MUSE -Medigus Ultrasonic Surgical Endostapler
9.6. Stretta Therapy
10. Gastroesophageal Reflux Disease Devices Market, by Dosage Form
10.1. Introduction
10.2. Liquid
10.3. Solid
11. Gastroesophageal Reflux Disease Devices Market, by Route of Administration
11.1. Introduction
11.2. Oral
11.3. Parenteral
12. Gastroesophageal Reflux Disease Devices Market, by End-User
12.1. Introduction
12.2. Government
12.3. Hospitals
12.4. Medical Practitioners
13. Americas Gastroesophageal Reflux Disease Devices Market
13.1. Introduction
13.2. Argentina
13.3. Brazil
13.4. Canada
13.5. Mexico
13.6. United States
14. Asia-Pacific Gastroesophageal Reflux Disease Devices Market
14.1. Introduction
14.2. Australia
14.3. China
14.4. India
14.5. Indonesia
14.6. Japan
14.7. Malaysia
14.8. Philippines
14.9. Singapore
14.10. South Korea
14.11. Taiwan
14.12. Thailand
14.13. Vietnam
15. Europe, Middle East & Africa Gastroesophageal Reflux Disease Devices Market
15.1. Introduction
15.2. Denmark
15.3. Egypt
15.4. Finland
15.5. France
15.6. Germany
15.7. Israel
15.8. Italy
15.9. Netherlands
15.10. Nigeria
15.11. Norway
15.12. Poland
15.13. Qatar
15.14. Russia
15.15. Saudi Arabia
15.16. South Africa
15.17. Spain
15.18. Sweden
15.19. Switzerland
15.20. Turkey
15.21. United Arab Emirates
15.22. United Kingdom
16. Competitive Landscape
16.1. Market Share Analysis, 2023
16.2. FPNV Positioning Matrix, 2023
16.3. Competitive Scenario Analysis
16.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET RESEARCH PROCESS
FIGURE 2. GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
FIGURE 7. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2023 VS 2030 (%)
FIGURE 9. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGERY TYPE, 2023 VS 2030 (%)
FIGURE 11. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGERY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DEVICE TYPE, 2023 VS 2030 (%)
FIGURE 13. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DEVICE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DOSAGE FORM, 2023 VS 2030 (%)
FIGURE 15. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DOSAGE FORM, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
FIGURE 17. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 19. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. AMERICAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 21. AMERICAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 23. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 24. ASIA-PACIFIC GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 25. ASIA-PACIFIC GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 26. EUROPE, MIDDLE EAST & AFRICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 27. EUROPE, MIDDLE EAST & AFRICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 28. GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 29. GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET DYNAMICS
TABLE 7. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ESOPHAGOSCOPES & GASTROSCOPES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY FUNDOPLICATION DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MANOMETRY SYSTEM, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PH MONITORING SYSTEM, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SPHINCTER AUGMENTATION DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ULTRASONIC SURGICAL ENDOSTAPLER, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC PROCEDURES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY FUNDOPLICATION PROCEDURES, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MAGNETIC SPHINCTER AUGMENTATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY RADIOFREQUENCY THERMAL ABLATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY INVASIVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY LINX REFLUX MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MEDIGUS ULTRASONIC SURGICAL ENDOSTAPLER, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NON-INVASIVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ENDOCINCH ENDOLUMMINAL GASTROPLICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ENDOSCOPIC PLICATOR SYSTEM, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ESOPHYX, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PLEXIGLAS POLY-METHYL-METHACRYLATE MICROSPHERES, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY STRETTA, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY BRAVO REFLUX TESTING SYSTEM, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DIGITRAPPER REFLUX TESTING SYSTEM, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY LINX MANAGEMENT SYSTEM, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MUSE -MEDIGUS ULTRASONIC SURGICAL ENDOSTAPLER, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY STRETTA THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY LIQUID, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SOLID, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PARENTERAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY GOVERNMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MEDICAL PRACTITIONERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 60. ARGENTINA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 61. ARGENTINA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 62. ARGENTINA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
TABLE 63. ARGENTINA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
TABLE 64. ARGENTINA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
TABLE 65. ARGENTINA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 66. ARGENTINA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 67. ARGENTINA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 68. ARGENTINA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 69. BRAZIL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 70. BRAZIL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 71. BRAZIL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
TABLE 72. BRAZIL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
TABLE 73. BRAZIL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
TABLE 74. BRAZIL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 75. BRAZIL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 76. BRAZIL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 77. BRAZIL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 78. CANADA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 79. CANADA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 80. CANADA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
TABLE 81. CANADA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
TABLE 82. CANADA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
TABLE 83. CANADA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 84. CANADA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 85. CANADA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 86. CANADA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 87. MEXICO GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 88. MEXICO GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 89. MEXICO GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
TABLE 90. MEXICO GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
TABLE 91. MEXICO GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
TABLE 92. MEXICO GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 93. MEXICO GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 94. MEXICO GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 95. MEXICO GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 96. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 97. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 98. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
TABLE 99. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
TABLE 100. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
TABLE 101. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 102. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 103. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 104. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 105. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 106. ASIA-PACIFIC GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 107. ASIA-PACIFIC GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 108. ASIA-PACIFIC GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
TABLE 109. ASIA-PACIFIC GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
TABLE 110. ASIA-PACIFIC GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
TABLE 111. ASIA-PACIFIC GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 112. ASIA-PACIFIC GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 113. ASIA-PACIFIC GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 114. ASIA-PACIFIC GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 115. ASIA-PACIFIC GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 116. AUSTRALIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 117. AUSTRALIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 118. AUSTRALIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
TABLE 119. AUSTRALIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
TABLE 120. AUSTRALIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
TABLE 121. AUSTRALIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 122. AUSTRALIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 123. AUSTRALIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 124. AUSTRALIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 125. CHINA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 126. CHINA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 127. CHINA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
TABLE 128. CHINA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
TABLE 129. CHINA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
TABLE 130. CHINA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 131. CHINA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 132. CHINA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 133. CHINA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 134. INDIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 135. INDIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 136. INDIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
TABLE 137. INDIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
TABLE 138. INDIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
TABLE 139. INDIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 140. INDIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 141. INDIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 142. INDIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 143. INDONESIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 144. INDONESIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 145. INDONESIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
TABLE 146. INDONESIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
TABLE 147. INDONESIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
TABLE 148. INDONESIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 149. INDONESIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 150. INDONESIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 151. INDONESIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 152. JAPAN GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 153. JAPAN GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 154. JAPAN GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
TABLE 155. JAPAN GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
TABLE 156. JAPAN GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
TABLE 157. JAPAN GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 158. JAPAN GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 159. JAPAN GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 160. JAPAN GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 161. MALAYSIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 162. MALAYSIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 163. MALAYSIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
TABLE 164. MALAYSIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
TABLE 165. MALAYSIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
TABLE 166. MALAYSIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 167. MALAYSIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 168. MALAYSIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 169. MALAYSIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 170. PHILIPPINES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 171. PHILIPPINES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 172. PHILIPPINES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
TABLE 173. PHILIPPINES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
TABLE 174. PHILIPPINES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
TABLE 175. PHILIPPINES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 176. PHILIPPINES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 177. PHILIPPINES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 178. PHILIPPINES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 179. SINGAPORE GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 180. SINGAPORE GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 181. SINGAPORE GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
TABLE 182. SINGAPORE GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
TABLE 183. SINGAPORE GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
TABLE 184. SINGAPORE GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 185. SINGAPORE GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 186. SINGAPORE GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 187. SINGAPORE GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 188. SOUTH KOREA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 189. SOUTH KOREA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 190. SOUTH KOREA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
TABLE 191. SOUTH KOREA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
TABLE 192. SOUTH KOREA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
TABLE 193. SOUTH KOREA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 194. SOUTH KOREA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 195. SOUTH KOREA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 196. SOUTH KOREA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 197. TAIWAN GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 198. TAIWAN GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 199. TAIWAN GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
TABLE 200. TAIWAN GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
TABLE 201. TAIWAN GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
TABLE 202. TAIWAN GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 203. TAIWAN GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 204. TAIWAN GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 205. TAIWAN GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 206. THAILAND GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 207. THAILAND GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 208. THAILAND GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
TABLE 209. THAILAND GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
TABLE 210. THAILAND GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
TABLE 211. THAILAND GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 212. THAILAND GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 213. THAILAND GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 214. THAILAND GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 215. VIETNAM GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 216. VIETNAM GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 217. VIETNAM GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
TABLE 218. VIETNAM GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
TABLE 219. VIETNAM GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
TABLE 220. VIETNAM GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 221. VIETNAM GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 222. VIETNAM GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 223. VIETNAM GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 224. EUROPE, MIDDLE EAST & AFRICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 225. EUROPE, MIDDLE EAST & AFRICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 226. EUROPE, MIDDLE EAST & AFRICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
TABLE 227. EUROPE, MIDDLE EAST & AFRICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
TABLE 228. EUROPE, MIDDLE EAST & AFRICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
TABLE 229. EUROPE, MIDDLE EAST & AFRICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 230. EUROPE, MIDDLE EAST & AFRICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 231. EUROPE, MIDDLE EAST & AFRICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 232. EUROPE, MIDDLE EAST & AFRICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 233. EUROPE, MIDDLE EAST & AFRICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 234. DENMARK GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 235. DENMARK GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 236. DENMARK GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
TABLE 237. DENMARK GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
TABLE 238. DENMARK GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
TABLE 239. DENMARK GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 240. DENMARK GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 241. DENMARK GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 242. DENMARK GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 243. EGYPT GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 244. EGYPT GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 245. EGYPT GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
TABLE 246. EGYPT GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
TABLE 247. EGYPT GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
TABLE 248. EGYPT GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 249. EGYPT GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 250. EGYPT GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 251. EGYPT GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 252. FINLAND GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 253. FINLAND GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 254. FINLAND GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
TABLE 255. FINLAND GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
TABLE 256. FINLAND GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
TABLE 257. FINLAND GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 258. FINLAND GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 259. FINLAND GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 260. FINLAND GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 261. FRANCE GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 262. FRANCE GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 263. FRANCE GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
TABLE 264. FRANCE GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
TABLE 265. FRANCE GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
TABLE 266. FRANCE GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 267. FRANCE GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 268. FRANCE GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 269. FRANCE GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 270. GERMANY GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 271. GERMANY GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 272. GERMANY GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
TABLE 273. GERMANY GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
TABLE 274. GERMANY GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
TABLE 275. GERMANY GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 276. GERMANY GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 277. GERMANY GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 278. GERMANY GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 279. ISRAEL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 280. ISRAEL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 281. ISRAEL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
TABLE 282. ISRAEL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
TABLE 283. ISRAEL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NON-INVASIVE,

Companies Mentioned

The leading players in the Gastroesophageal Reflux Disease Devices Market, which are profiled in this report, include:
  • Addex Pharmaceuticals Ltd.
  • Aros Pharma ApS
  • AstraZeneca PLC
  • C. R. Bard, Inc.
  • Eisai Co., Ltd.
  • EndoGastric Solutions, Inc.
  • Frost & Sullivan Inc.
  • Johnson & Johnson Services, Inc.
  • KARL STORZ SE & Co. KG
  • MediGus Ltd.
  • Olympus Corporation
  • PENTAX Europe GmbH
  • Pfizer Inc.
  • Takeda Pharmaceutical Company Limited
  • The Procter & Gamble Company

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages188
PublishedOctober 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 6.65 Billion
Forecasted Market Value ( USD ) by 2030 $ 14.35 Billion
Compound Annual Growth Rate13.6%
Regions CoveredGlobal
No. of Companies Mentioned15

Related Topics

Related Reports

Gastroesophageal Reflux Disease (GERD) Global Market Report 2024 - Product Image

Gastroesophageal Reflux Disease (GERD) Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Gastroesophageal Reflux Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 - Product Image

Gastroesophageal Reflux Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

  • Report
  • 132 Pages
  • Global
From
Gastroesophageal Reflux Disease (Gerd) Market 2024-2028 - Product Image

Gastroesophageal Reflux Disease (Gerd) Market 2024-2028

  • Report
  • 176 Pages
  • Global
From
Gastroesophageal Reflux Disease - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Image

Gastroesophageal Reflux Disease - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • 120 Pages
  • Global
From
Endoluminal Suturing Device Market Report: Trends, Forecast and Competitive Analysis to 2030 - Product Image

Endoluminal Suturing Device Market Report: Trends, Forecast and Competitive Analysis to 2030

  • Report
  • 150 Pages
  • Global
From

About the Gastroesophageal Reflux Disease Devices Market

In the field of gastroenterology, the gastroesophageal reflux disease (GERD) devices market encompasses a range of products designed to diagnose, monitor, and treat the symptoms and complications of GERD. This condition is characterized by the backward flow of stomach contents into the esophagus, which can cause heartburn, regurgitation, and other discomforts. Devices in this market include diagnostic tools such as pH monitoring systems and esophageal manometry systems, therapeutic devices such as proton pump inhibitors (PPIs) and H2 blockers (both of which may be considered devices in some contexts due to their delivery mechanisms), and surgical implants like esophageal sphincter augmentation devices. Advanced endoscopic devices, including those that can perform tissue remodeling or deliver radiofrequency ablation to the lower esophageal sphincter, also form an important part of this market. These treatments can offer alternatives to traditional surgical interventions, with the aim of improving patient outcomes and quality of life. Several companies contribute to the diversity and advancement of the GERD devices market. Medtronic is known for its diagnostic tools and therapeutic equipment. Ethicon, a subsidiary of Johnson & Johnson, provides surgical devices for the treatment of GERD. Olympus Corporation offers advanced endoscopic devices. Other key players include Diversatek Healthcare with its diagnostic solutions, Torax Medical which specializes in sphincter augmentation devices, and EndoGastric Solutions which develops innovative approaches to endoscopic GERD treatments. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.